Physician profile
Robert L Davis
NPI 1275513509
$1,919.38
in general payments reported to CMS, 2019-2025
21 companies · $42.69 in 2025
The $42.69 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $556 · 2020: $163 · 2021: $261 · 2022: $578 · 2023: $211 · 2024: $109 · 2025: $42.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $362.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $346.01 | 2019-2025 | Total30, Precision7 |
| Johnson & Johnson Vision Care, INC. | $267.58 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $190.41 | 2019-2021 | |
| Shire North American Group INC | $154.99 | 2019 | |
| Sight Sciences, INC. | $152.49 | 2019-2022 | |
| Menicon America INC | $145.09 | 2021-2022 | |
| Allergan, INC. | $115.07 | 2019-2021 | |
| Abb Con-Cise Optical Group LLC | $92.18 | 2022-2023 | Contact Lens, Spectacle Lenses |
| Novartis Pharmaceuticals Corporation | $65.87 | 2020-2021 | |
| Tearlab Corp | $57.67 | 2023 | Tearlab Osmolarity System |
| Horizon Therapeutics Plc | $52.84 | 2023 | Tepezza |
| Amgen INC. | $48.37 | 2024-2025 | Tepezza |
| Biotissue Holdings INC. | $44.60 | 2022 | |
| Bausch & Lomb Americas INC. | $39.62 | 2023-2024 | Xiidra, Biotrue One Day, Infuse |
| Tarsus Pharmaceuticals, INC. | $31.04 | 2024 | Xdemvy |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $23.86 | 2023 | |
| Abbvie INC. | $21.99 | 2022 | |
| Dompe US, INC. | $19.74 | 2022 | |
| Oyster Point Pharma, INC. | $18.47 | 2022 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Visioneering Technologies, INC. | $14.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.